Detournay, B.; Pribil, C.; Jourdanne, C.; Price, M. - In: The European Journal of Health Economics 3 (2002) 3, pp. 149-155
A budget impact model was used to estimate the effect of introducing inhaled salmeterol/fluticasone propionate combination on asthma drug-related costs in France. The model is based on disease prevalence, drug use, drug acquisition cost and sales forecasting data specific to France. It takes the...